Skip to content

How good are new CD4 cells on HAART?

Latest News from ICAAC

Resistance to ddI and d4T may be underestimated

Are you being treated well?

Most people with Hep C not developing liver toxicity on HAART

Delavirdine setback in Europe

Chicago: conference summaries

Europe rejects license for delavirdine, delays on amprenavir

Pressure builds for drug price cuts as Durban kicks off